Skip to main content
SLSBio(Specialty Lab Solution Bio) Co., Ltd logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd — Investor Relations & Filings

Ticker · 246250 ISIN · KR7246250005 KO Professional, scientific and technical activities
Open in API
Filings indexed 261 across all filing types
Latest filing 2020-11-25 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 246250

About SLSBio(Specialty Lab Solution Bio) Co., Ltd

http://www.slabs.co.kr/

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a company specializing in laboratory solutions and support services for the pharmaceutical and biotechnology sectors. Its primary offerings include pharmaceutical quality control testing, clinical trial sample analysis, bioequivalence studies, drug stability testing, and new drug development support. In addition to its service portfolio, the company develops and manufactures diagnostic technologies, reagents, and other biological agents, supporting various stages of the drug development and commercialization lifecycle.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to previously granted stock options, including the cancellation of options due to employee resignation. This type of disclosure regarding stock option grants and amendments falls under the category of share-related capital changes or regulatory filings. Given the specific nature of stock option grants and their amendments, it is best classified as a regulatory filing (RNS) as it does not fit into the specific categories of director dealings (which are personal trades) or share issues (which are typically new issuances).
2020-11-25 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) and specifically a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including the number of shares and the list of recipients. This type of disclosure regarding capital structure changes and employee compensation via stock options falls under the category of share issues or capital changes, which is best classified as 'SHA' (Share Issue/Capital Change) within the provided schema.
2020-11-25 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of shares granted and the list of recipients due to employee resignations. In the context of financial filings, reports concerning the issuance of stock options or changes to capital structure/share-based compensation are classified under 'Share Issue/Capital Change' (SHA) as they directly impact the company's equity and capital structure.
2020-11-25 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of shares granted and the list of recipients due to employee resignations. In the context of financial filings, reports concerning the issuance of stock options or changes to capital structure/share-based compensation are classified under 'Share Issue/Capital Change' (SHA) as they directly impact the company's equity and capital structure.
2020-11-25 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of shares granted and the list of recipients due to employee resignations. In the context of financial filings, reports concerning the issuance of stock options or changes to capital structure/share-based compensation that do not fit into specific categories like 'Director's Dealing' or 'Share Issue' are classified under 'Regulatory Filings' (RNS) as a fallback for miscellaneous corporate announcements.
2020-11-25 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) and specifically a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including the number of shares and the list of recipients. This type of disclosure regarding capital structure changes and employee compensation via stock options falls under the category of share issues or capital changes, which is best classified as 'SHA' (Share Issue/Capital Change) within the provided schema.
2020-11-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.